120 Years of PARI – Innovation Built on Tradition

A vintage inhalation device with mouthpiece and hose stands on a table in front of a framed picture.

Our History – Together for every breath

Since 1906, PARI has shaped the development of modern inhalation therapies. For more than 120 years, our innovations have set standards in respiratory care, guided by a commitment that continues to unite us today: making breathing easier for people.

For PARI, innovation has always been more than technology. Every advancement has pursued a single goal: to measurably improve the lives of patients and those who care for them. Real progress is achieved when innovation places people at its center.

Equally important to us is close exchange with physicians, respiratory therapists, as well as with research and engineering. We also provide reliable, easy-to-understand information, because treatment outcomes can improve when conditions and therapies are well understood.

1906

1920

1950

1953

1968

1970

1972

1985

1992

1997

2001

2004

2005

2006

2015

2016

2019

2023

2024

A black-and-white photo of an old laboratory with long workbenches, technical equipment, cables, and stools in a workspace.

Development of the PARI large-capacity nebulizer – a group of people stands around a table and looks at a device from which steam is emitted.

The system was designed for use by several people within a shared space and already generated aerosols with clinically relevant particle sizes – an early milestone in modern aerosol therapy.

Co-founder of the Board of Trustees for Aerosol Research – Several specialist books and journals on the topic of aerosols and inhalation are located in one area.

Co-founding of the Aerosol Research Council. PARI strengthens scientific collaboration between medicine and physics and promotes fundamental research in aerosol technology.

Its fine atomization enables applications that can specifically reach the lower airways.

Market launch of the first PARI BOY – Medical device for inhalation is on a table, in the background a person in white clothing.

It makes inhalation therapy feasible at home for the first time and becomes a widely used device in families for many years.

*Handbook of Inhalation Therapy* — The cover features the title *Handbook of Inhalation Therapy*, accompanied by an image of waves and foam alongside an inhaler.

With its “Compendium of Inhalation Therapy,” PARI is publishing well-founded information on respiratory therapy that is accessible to laypeople for the first time. A quality standard that continues to this day.

Mehrstöckiges Gebäude hinter kahlen Bäumen, umgeben von parkenden Autos, in einer Schwarz-Weiß-Aufnahme.

The PARI Universal enables mobile inhalation and expands the range of possible applications.

Establishment of branches in the USA, France, and Great Britain

Frau arbeitet an einem Laborgerät mit mehreren runden Metallkammern und Lochplatten auf einer Halterung.

ARI was founded as an internal aerosol research centre in Munich and was later transformed into PARI Pharma, where optimised formulations of existing active pharmaceutical ingredients and specialised devices for pharmaceutical partners are developed.

Market launch of the PARI BOY N family – Three inhalation devices in black and green with mouthpieces, one with a child-friendly figure as an attachment.

The PARI SINUS makes it possible for the first time to perform inhalation targeted at the paranasal sinuses.

In the same year, PARI expands its portfolio with the first VORTEX® valved holding chamber for use with pressurized metered-dose inhalers.

The eFlow® inhalation system sets new technological standards

Vibrating membrane technology enables significantly shorter inhalation times and a more everyday-friendly application.

Introduction of the PARI BOY S family as a logical further development

Market launch of VELOX®, Kitabis® Pak and Vantobra®

With VELOX, PARI launches a compact vibrating membrane nebuliser for the treatment of acute and chronic respiratory diseases. Kitabis® Pak and Vantobra®, are PARIs´ first proprietary inhaled medicinal products.

Introduction of the current PARI BOY-Generation

Establishment of branches in Japan and China

With the acquisition of Nortev Ltd., PARI enters the Animal Health sector.

120 Years of PARI – Innovation Built on Tradition

Our History – Together for every breath

PARI is founded as a small manufacturing workshop in Wuppertal, Germany.

Development of the “PARI large-volume nebuliser”

PARI promotes scientific collaboration between medicine and physics

Patenting of the first PARI nozzle

Market launch of the first PARI BOY

“Compendium of Inhalation Therapy”

Establishment of the company headquarters in Starnberg.

The PARI Universal enables mobile inhalation, expanding the use of inhalation therapy beyond the home environment.

Establishment of subsidiaries in the United States, France, and the United Kingdom to better support patients and healthcare professionals locally.

Founding of the Aerosol Research Institute (ARI) – later PARI Pharma GmbH – in Munich.

Market launch of the PARI BOY N family – with modernized technology, improved ease of use, and enhanced performance.

With PARI SINUS, inhalation specifically targeting the paranasal sinuses becomes possible for the first time.

The eFlow® inhalation system sets new technological standards

Introduction of the PARI BOY S family as a consistent evolution of the proven device generation.

Market launch of VELOX®, Kitabis® Pak und Vantobra®

Market launch of PARI Protect® - the first inhalation solution containing natural Ectoin.

Introduction of the current PARI BOY generation with modernized technology and further improved ease of use.

Establishment of subsidiaries in Japan and China.

New, optimized VORTEX® masks for babies and children provide a more comfortable application for families with infants and young children.